Cardiovascular Diseases Clinical Trial
— SPICAOfficial title:
The Swedish Spinal Cord Injury Study on Cardiopulmonary and Autonomic Impairment
NCT number | NCT03515122 |
Other study ID # | 2017-0765 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | November 15, 2017 |
Est. completion date | June 30, 2018 |
Verified date | May 2019 |
Source | Lund University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The main aim of this study is to gain an in-depth knowledge of cardiopulmonary and autonomic health consequences, and related risk factors among people with long-term high-level spinal cord injury. The result of this study will form the basis for further research to improve prevention strategies and risk prediction of cardiopulmonary disorders in people with spinal cord injury.
Status | Completed |
Enrollment | 125 |
Est. completion date | June 30, 2018 |
Est. primary completion date | June 30, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years to 65 Years |
Eligibility |
Inclusion criteria: - Traumatic SCI - SCI duration >5 years - Neurological level of lesion C1-T6 - ASIA Impairment Scale A-C - Resident in Skåne, Sweden - No dependency of full-time ventilation support Control group will consist of matched controls from the Swedish Cardiopulmonary and Bioimage Study's data of the general population. |
Country | Name | City | State |
---|---|---|---|
Sweden | Rehabilitation medicine Research Group | Lund |
Lead Sponsor | Collaborator |
---|---|
Lund University | Skane University Hospital |
Sweden,
Bergström G, Berglund G, Blomberg A, Brandberg J, Engström G, Engvall J, Eriksson M, de Faire U, Flinck A, Hansson MG, Hedblad B, Hjelmgren O, Janson C, Jernberg T, Johnsson Å, Johansson L, Lind L, Löfdahl CG, Melander O, Östgren CJ, Persson A, Persson M, Sandström A, Schmidt C, Söderberg S, Sundström J, Toren K, Waldenström A, Wedel H, Vikgren J, Fagerberg B, Rosengren A. The Swedish CArdioPulmonary BioImage Study: objectives and design. J Intern Med. 2015 Dec;278(6):645-59. doi: 10.1111/joim.12384. Epub 2015 Jun 19. — View Citation
Devivo MJ. Epidemiology of traumatic spinal cord injury: trends and future implications. Spinal Cord. 2012 May;50(5):365-72. doi: 10.1038/sc.2011.178. Epub 2012 Jan 24. Review. — View Citation
Groah SL, Charlifue S, Tate D, Jensen MP, Molton IR, Forchheimer M, Krause JS, Lammertse DP, Campbell M. Spinal cord injury and aging: challenges and recommendations for future research. Am J Phys Med Rehabil. 2012 Jan;91(1):80-93. doi: 10.1097/PHM.0b013e31821f70bc. Review. — View Citation
Schilero GJ, Radulovic M, Wecht JM, Spungen AM, Bauman WA, Lesser M. A center's experience: pulmonary function in spinal cord injury. Lung. 2014 Jun;192(3):339-46. doi: 10.1007/s00408-014-9575-8. Epub 2014 Apr 11. — View Citation
Warburton DE, Eng JJ, Krassioukov A, Sproule S; the SCIRE Research Team. Cardiovascular Health and Exercise Rehabilitation in Spinal Cord Injury. Top Spinal Cord Inj Rehabil. 2007 Summer;13(1):98-122. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Coronary artery calcium score | Measures the amount of calcium in the coronary arteries from computed tomography imaging. Scores from 0 to >1000, a higher value represents a worse outcome. Value >0 indicates coronary atherosclerosis. | Day 1 | |
Primary | Intima media thickness in the carotid arteries | Ultrasound of carotid arteries to measure intima media thickness | Day 1 | |
Primary | Assesses atherosclerosis in the coronary arteries | Coronary CT Angiography | Day 1 | |
Primary | Prevalence of structural changes in the lung tissue | High resolution CT scan | Day 1 | |
Primary | Ectopic fat distribution | CT body composition of epicardium, liver, abdomen and muscle | Day 1 | |
Primary | Heart rate response to deep breathing | Measures electrocardiography the activity of the autonomic nervous system based on the time and frequency domain indices of heart rate variability during deep breathing. | Day 1 | |
Primary | Orthostatic blood pressure | Measures systolic and diastolic blood pressure changes from supine position and after 3 minutes in seating position. | Day 1 | |
Primary | Plaques in the carotid arteries | Ultrasound of carotid arteries to measure and characterize plaques. | Day 1 | |
Secondary | Questionnaire | self-reported health, lifestyle, social determinants, living conditions and medical history | Day 1 | |
Secondary | Spinal Cord Injury Spasticity Evaluation Tool (SCI-SET) | Self-reported spasticity scale that measures the impact of spasticity in activities of daily living. Ranges from -105 to 105. Low values represents a worse outcome | Day 1 | |
Secondary | Sense of Coherence Scale (SOC-13) | To assess the 3 dimensions of the SOC concept: comprehensibility (5 items), manageability (4 items), and meaningfulness (4 items). Value ranges from 13 to 91 and low values represent a worse outcome. | Day 1 | |
Secondary | Hospital Anxiety and Depression Scale (HADS) | Screening instrument for anxiety and depression. Consists of two subscales, one for depression and one for anxiety each ranging from 0-21, high value represents a worse outcome. | Day 1 | |
Secondary | Spinal Cord Independence Measure (SCIM III) | SCIM III comprises 19 areas of activities of daily living grouped into 3 subscales: self-care, respiratory and sphincter management, and mobility and measure self-reported activity limitation. SCIM III ranges from 0-100 and a low value represents a worse outcome. | Day 1 | |
Secondary | Modified Ashworth Scale | Clinical examination of spasticity in specific muscles of the upper and lower extremities. The scale ranges from 0-4 with increasing scores indicating increased spasticity. | Day 1 | |
Secondary | American Spinal Injury Association (ASIA) Impairment Scale | Measures the extent of spinal cord injury and the neurological level of injury. The extent of injury is classified as A-E. A (complete injury); B (sensory incomplete injury); C (motor incomplete injury, more than half of key muscle functions below the neurological level have a muscle grade 2 or less); D (motor incomplete injury, at least half of key muscle functions below the neurological level have a muscle grade 3 or more); E (normal sensory and motor function). i.e. from complete to normal neurological function. Thus A represents a worse outcome than E. The neurological level of injury reflects the most rostral spinal cord level with normal sensory and motor function. | Day 1 | |
Secondary | Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) | Measures the occurrence and severity of autonomic dysreflexia (AD) and hypotension in spinal cord injury. Consists of two subscales ranging from 0-204 (AD) and 0-232 (hypotension) and a high value represents a worse outcome. | Day 1 | |
Secondary | Total cholesterol | Analysis of venous blood sample for total cholesterol levels | Day 1 | |
Secondary | High density lipoproteins (HDL) | Analysis of venous blood sample for total HDL-levels | Day 1 | |
Secondary | Low density lipoproteins (LDL) | Analysis of venous blood sample for LDL-levels | Day 1 | |
Secondary | Triglycerides | Analysis of venous blood sample for triglycerides levels | Day 1 | |
Secondary | Fasting plasma glucose | Analysis of venous blood sample for fasting plasma glucose level | Day 1 | |
Secondary | Glycated hemoglobin (HbA1c) | Analysis of venous blood sample for HbA1c level | Day 1 | |
Secondary | high sensitive C-reactive protein (hsCRP) | Analysis of venous blood sample for hsCRP level | Day 1 | |
Secondary | Cystatin C | Analysis of venous blood sample for Cystatin C level | Day 1 | |
Secondary | Creatinine | Analysis of venous blood sample for Creatinine level | Day 1 | |
Secondary | Urate | Analysis of venous blood sample for Urate level | Day 1 | |
Secondary | Hemoglobin | Analysis of venous blood sample for Hemoglobin level | Day 1 | |
Secondary | Erythrocytes | Analysis of venous blood sample for erythrocytes level | Day 1 | |
Secondary | Erythrocyte volume fraction (EVF) | Analysis of venous blood sample for EVF level | Day 1 | |
Secondary | Leukocytes | Analysis of venous blood sample for leukocytes level | Day 1 | |
Secondary | Trombocytes | Analysis of venous blood sample for trombocytes level | Day 1 | |
Secondary | Erythrocytes Mean Corpuscular Hemoglobin (Erc-MCH) | Analysis of venous blood sample for Erc-MCH level | Day 1 | |
Secondary | Erythrocytes Mean Corpuscular Volume (Erc-MCV) | Analysis of venous blood sample for Erc-MCV level | Day 1 | |
Secondary | Neutrophils | Analysis of venous blood sample for neutrophils level | Day 1 | |
Secondary | Eosinophils | Analysis of venous blood sample for Eosinophils level | Day 1 | |
Secondary | Basophils | Analysis of venous blood sample for Basophils level | Day 1 | |
Secondary | Lymphocytes | Analysis of venous blood sample for lymphocytes level | Day 1 | |
Secondary | Monocytes | Analysis of venous blood sample for monocytes level | Day 1 | |
Secondary | Absolute glomerular filtration rate (GFR) | Calculated absolute GFR from Cystatin C level, body height, body weight, age and gender. | Day 1 | |
Secondary | Body weight | Recorded in kilograms with a portable scale for wheelchairs. | Day 1 | |
Secondary | Body height | Recorded in centimeters in supine position using a flexible measure tape | Day 1 | |
Secondary | Waist circumference | Recorded in centimeters in supine position using a flexible measure tape | Day 1 | |
Secondary | Hip circumference | Recorded in centimeters in supine position using a flexible measure tape | Day 1 | |
Secondary | Body mass index | Produced by dividing the body weight in kilograms with the body height in meters to the power of two | Day 1 | |
Secondary | Accelerometry | Measures ambulatory activity for seven days | Seven days | |
Secondary | Resting blood pressure | Standard resting systolic and diastolic blood pressure | Day 1 | |
Secondary | Ankle-brachial index | Measures atherosclerosis in the lower extremities by dividing the systolic blood pressure at the ankle with the systolic blood pressure of the arm. | Day 1 | |
Secondary | Ambulatory 24-hour blood pressure | Monitors systolic and diastolic blood pressures every 30 minutes over 24 hours | Day 1 | |
Secondary | Electrocardiography | Standard 12-lead ECG recording | Day 1 | |
Secondary | 24-hour Holter-ECG | Monitors the heart activity | Day 1 | |
Secondary | Advanced glycation endproduct (AGE) | Measures AGE in the skin | Day 1 | |
Secondary | Spirometry | Dynamic spirometry | Day 1 | |
Secondary | Gas diffusing capacity (DLCO) | Measures diffusing capacity of the lungs using the single breath method | Day 1 | |
Secondary | Impulse oscillometry | Measures lung mechanics | Day 1 | |
Secondary | Arterial stiffness | Estimated by pulse wave analysis | Day 1 | |
Secondary | Arterial stiffness | Measured using pulse wave velocity | Day 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|